https://news.medxy.ai/zh/esophageal-leak-survival/Medxy AIzh2026-09-11T09:33:50-07:00食管切除术后重度吻合口漏对长期生存的影响：现代多中心队列研究的新证据 https://news.medxy.ai/ja/anastomotic-leak-impact/Medxy AIja2026-09-11T09:33:32-07:00食道切除術後の重症吻合部漏出は長期予後をどう変えるか：最新多施設コホートからの知見 https://news.medxy.ai/vi/72695-2/Medxy AIvi2026-09-11T09:33:11-07:00Tình trạng rò miệng nối nghiêm trọng sau phẫu thuật cắt thực quản ảnh hưởng như thế nào đến tiên lượng dài hạn? https://news.medxy.ai/impact-of-severe-anastomotic-leak-after-esophagectomy-on-long-term-survival-insights-from-a-modern-multicenter-cohort/Medxy AIen2026-09-11T09:32:50-07:00Impact of Severe Anastomotic Leak After Esophagectomy on Long-Term Survival: Insights from a Modern Multicenter Cohort https://news.medxy.ai/zh/global-hospital-infrastructure-pancreatic-surgery-mortality/Medxy AIzh2026-09-11T09:32:04-07:00全球医院基础设施与胰腺手术死亡率：来自医院资源指数的启示 https://news.medxy.ai/ja/hospital-resource-index/Medxy AIja2026-09-11T09:31:44-07:00膵臓手術後死亡率を左右する病院インフラとは？ Hospital Resource Indexが示す世界的エビデンス https://news.medxy.ai/vi/global-hospital-infrastructure/Medxy AIvi2026-09-11T09:31:19-07:00Cơ sở hạ tầng bệnh viện trên toàn cầu và tác động đến tử vong sau phẫu thuật tụy: Góc nhìn từ Chỉ số Tài nguyên Bệnh viện https://news.medxy.ai/global-hospital-infrastructure-and-its-impact-on-mortality-after-pancreas-surgery-insights-from-the-hospital-resource-index/Medxy AIen2026-09-11T09:30:59-07:00Global Hospital Infrastructure and Its Impact on Mortality After Pancreas Surgery: Insights from the Hospital Resource Index https://news.medxy.ai/zh/p53-interferon-pathway/Medxy AIzh2026-09-11T09:30:13-07:00p53 突变如何重塑子宫内膜癌中的 I 型干扰素通路：免疫调控新视角 https://news.medxy.ai/ja/p53-mutation-uterine-cancer/Medxy AIja2026-09-11T09:29:51-07:00子宮体癌における変異p53がI型インターフェロン経路に及ぼす影響：免疫調節の視点 https://news.medxy.ai/vi/mutant-p53-endometrial-cancer/Medxy AIvi2026-09-11T09:29:29-07:00Tác động của p53 đột biến lên biểu hiện con đường interferon type I trong ung thư nội mạc tử cung: những góc nhìn về điều hòa miễn dịch https://news.medxy.ai/impact-of-mutated-p53-on-type-i-interferon-pathway-expression-in-endometrial-cancer-immune-modulatory-insights/Medxy AIen2026-09-11T09:29:09-07:00Impact of Mutated p53 on Type I Interferon Pathway Expression in Endometrial Cancer: Immune Modulatory Insights https://news.medxy.ai/zh/early-cervical-cancer-surgery/Medxy AIzh2026-09-11T09:28:23-07:00早期宫颈癌中不使用子宫操纵器的微创根治性子宫切除术与开腹手术：大型倾向评分匹配队列的比较结局 https://news.medxy.ai/ja/minimally-invasive-hysterectomy-3/Medxy AIja2026-09-11T09:28:00-07:00子宮マニピュレーター非使用の低侵襲根治的子宮全摘術は開腹手術に代わり得るか：早期子宮頸癌における大規模傾向スコアマッチ解析 https://news.medxy.ai/vi/minimally-invasive-hysterectomy-2/Medxy AIvi2026-09-11T09:27:36-07:00Phẫu thuật cắt tử cung tận gốc xâm lấn tối thiểu không dùng dụng cụ thao tác tử cung so với phẫu thuật mở trong ung thư cổ tử cung giai đoạn sớm: Kết cục so sánh từ một đoàn hệ lớn ghép cặp theo điểm xu hướng https://news.medxy.ai/minimally-invasive-radical-hysterectomy-without-uterine-manipulator-vs-open-surgery-for-early-stage-cervical-cancer-comparative-outcomes-from-a-large-propensity-matched-cohort/Medxy AIen2026-09-11T09:27:14-07:00Minimally Invasive Radical Hysterectomy Without Uterine Manipulator vs Open Surgery for Early-Stage Cervical Cancer: Comparative Outcomes from a Large Propensity-Matched Cohort https://news.medxy.ai/zh/maternal-plasma-biomarkers/Medxy AIzh2026-09-11T09:26:31-07:00通过大规模蛋白质组学筛查发现母体血浆新型生物标志物，提升胎儿死亡检测能力 https://news.medxy.ai/ja/fetal-death-biomarkers/Medxy AIja2026-09-11T09:26:12-07:00胎児死亡の検出をさらに高精度に：大規模プロテオミクス解析で見いだされた新規母体血漿バイオマーカー https://news.medxy.ai/vi/stillbirth-biomarkers/Medxy AIvi2026-09-11T09:25:49-07:00Mở rộng khả năng phát hiện thai chết lưu: Xác định các biomarker mới trong huyết tương mẹ bằng phân tích proteomic quy mô lớn https://news.medxy.ai/advancing-fetal-death-detection-identification-of-novel-maternal-plasma-biomarkers-through-large-scale-proteomic-profiling/Medxy AIen2026-09-11T09:25:29-07:00Advancing Fetal Death Detection: Identification of Novel Maternal Plasma Biomarkers Through Large-Scale Proteomic Profiling https://news.medxy.ai/zh/vulvar-cancer-recurrence/Medxy AIzh2026-09-11T09:24:39-07:00外阴癌复发：发病率、生存与症状学——基于人群队列研究和最新证据的洞察 https://news.medxy.ai/ja/vulvar-cancer-recurrence-2/Medxy AIja2026-09-11T09:24:10-07:00外陰がん再発の発生率・生存・症状を読み解く：集団ベース研究と最新エビデンスからの知見 https://news.medxy.ai/vi/72646-2/Medxy AIvi2026-09-11T09:23:44-07:00Ung thư âm hộ tái phát: Tỷ lệ mắc, tỷ lệ sống còn và triệu chứng lâm sàng https://news.medxy.ai/incidence-survival-and-symptomatology-of-recurrence-in-vulvar-cancer-insights-from-population-based-cohort-studies-and-contemporary-evidence/Medxy AIen2026-09-11T09:23:19-07:00Incidence, Survival, and Symptomatology of Recurrence in Vulvar Cancer: Insights from Population-Based Cohort Studies and Contemporary Evidence https://news.medxy.ai/zh/gerd-burping-features/Medxy AIzh2026-09-11T09:21:51-07:00明确性 GERD 中过度性食管上嗳气的临床特征与预测因素揭秘 https://news.medxy.ai/ja/72640-2/Medxy AIja2026-09-11T09:21:28-07:00GERDにおける過剰な胃上部げっぷの臨床的特徴および予測因子の解明 https://news.medxy.ai/vi/excessive-belching-gerd/Medxy AIvi2026-09-11T09:21:09-07:00Nhận diện ợ hơi trên dạ dày quá mức trong GERD xác định rõ: các dấu ấn lâm sàng và yếu tố dự báo https://news.medxy.ai/unveiling-excessive-supragastric-belching-in-conclusive-gerd-clinical-insights-and-predictors/Medxy AIen2026-09-11T09:20:49-07:00Unveiling Excessive Supragastric Belching in Conclusive GERD: Clinical Insights and Predictors https://news.medxy.ai/ja/ischemic-stroke-burden/Medxy AIja2026-09-11T09:20:01-07:00糖尿病と心房細動に起因する虚血性脳卒中負担の世界動向：糖尿病関連負担の拡大 https://news.medxy.ai/vi/global-ischemic-stroke-burden/Medxy AIvi2026-09-11T09:19:38-07:00Xu hướng toàn cầu về gánh nặng đột quỵ thiếu máu cục bộ do đái tháo đường so với rung nhĩ https://news.medxy.ai/global-trends-in-the-burden-of-ischemic-stroke-attributable-to-diabetes-versus-atrial-fibrillation/Medxy AIen2026-09-11T09:19:15-07:00Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation https://news.medxy.ai/zh/72628-2/Medxy AIzh2026-09-11T08:50:45-07:00吸烟、呼出气一氧化碳与帕金森病发病有关 https://news.medxy.ai/ja/smoking-co2-parkinsons-risk/Medxy AIja2026-09-11T08:50:23-07:00喫煙・呼気一酸化炭素・パーキンソン病リスクの関係：疫学的知見と機序的考察 https://news.medxy.ai/vi/smoking-carbon-monoxide-parkinson/Medxy AIvi2026-09-11T08:49:58-07:00Hút thuốc, carbon monoxide trong khí thở ra và nguy cơ bệnh Parkinson: Góc nhìn dịch tễ học và cơ chế sinh học https://news.medxy.ai/smoking-exhaled-carbon-monoxide-and-parkinsons-disease-risk-epidemiological-insights-and-mechanistic-perspectives/Medxy AIen2026-09-11T08:49:35-07:00Smoking, Exhaled Carbon Monoxide, and Parkinson’s Disease Risk: Epidemiological Insights and Mechanistic Perspectives https://news.medxy.ai/ja/mc1r-parkinsons-progress/Medxy AIja2026-09-11T08:48:29-07:00MC1R一般変異とパーキンソン病進行の関連 https://news.medxy.ai/vi/mc1r-variants-parkinson/Medxy AIvi2026-09-11T08:48:09-07:00Các biến thể MC1R thường gặp và tiến triển bệnh Parkinson https://news.medxy.ai/common-mc1r-variants-and-parkinson-disease-progression/Medxy AIen2026-09-11T08:47:52-07:00Common MC1R Variants and Parkinson Disease Progression https://news.medxy.ai/zh/freestyle-libre-pro-iq/Medxy AIzh2026-09-11T08:47:03-07:00FreeStyle Libre Pro iQ 连续葡萄糖监测在症状前1型糖尿病中的应用：早期识别与风险分层的新进展 https://news.medxy.ai/ja/freestyle-libre-pro-monitoring/Medxy AIja2026-09-11T08:46:44-07:00FreeStyle Libre Pro iQによる持続血糖モニタリング：症候出現前1型糖尿病における早期発見とリスク層別化の新展開 https://news.medxy.ai/vi/continuous-glucose-monitoring/Medxy AIvi2026-09-11T08:46:21-07:00Theo dõi glucose liên tục bằng FreeStyle Libre Pro iQ ở đái tháo đường týp 1 tiền triệu chứng: Tiến bộ trong phát hiện sớm và phân tầng nguy cơ https://news.medxy.ai/continuous-glucose-monitoring-using-the-freestyle-libre-pro-iq-in-presymptomatic-type-1-diabetes-advancements-in-early-detection-and-risk-stratification/Medxy AIen2026-09-11T08:45:58-07:00Continuous Glucose Monitoring Using the FreeStyle Libre Pro iQ in Presymptomatic Type 1 Diabetes: Advancements in Early Detection and Risk Stratification https://news.medxy.ai/zh/autism-transgender-hormones/Medxy AIzh2026-09-11T08:45:00-07:00孤独症跨性别与性别多样化成人的性别肯定激素治疗：依从性挑战与优化策略 https://news.medxy.ai/ja/gender-affirming-hormone-therapy/Medxy AIja2026-09-11T08:44:37-07:00自閉症のあるトランスジェンダー・性別多様成人におけるジェンダー肯定的ホルモン療法：アドヒアランス最適化に向けた課題と方策 https://news.medxy.ai/vi/hormone-treatment-autism/Medxy AIvi2026-09-11T08:44:12-07:00Điều trị hormone khẳng định giới ở người trưởng thành chuyển giới và đa dạng giới mắc chứng tự kỷ: Thách thức và chiến lược tối ưu hóa tuân thủ https://news.medxy.ai/navigating-gender-affirming-hormone-therapy-in-autistic-transgender-and-gender-diverse-adults-challenges-and-strategies-for-optimal-adherence/Medxy AIen2026-09-11T08:43:48-07:00Navigating Gender-Affirming Hormone Therapy in Autistic Transgender and Gender Diverse Adults: Challenges and Strategies for Optimal Adherence https://news.medxy.ai/zh/congenital-adrenal-hyperplasia-4/Medxy AIzh2026-09-11T08:42:52-07:00先天性肾上腺皮质增生症患者终生住院负担与结局：来自瑞士人群队列研究的启示 https://news.medxy.ai/ja/congenital-adrenal-hyperplasia-3/Medxy AIja2026-09-11T08:42:28-07:00先天性副腎過形成の生涯にわたる入院負担と転帰：スイス集団ベースコホート研究からの知見 https://news.medxy.ai/vi/congenital-adrenal-hyperplasia-2/Medxy AIvi2026-09-11T08:42:02-07:00Gánh nặng nhập viện và kết cục của tăng sản thượng thận bẩm sinh theo suốt vòng đời: Góc nhìn từ một nghiên cứu đoàn hệ dân số Thụy Sĩ https://news.medxy.ai/hospitalization-burden-and-outcomes-in-congenital-adrenal-hyperplasia-across-the-lifespan-insights-from-a-swiss-population-based-cohort-study/Medxy AIen2026-09-11T08:41:38-07:00Hospitalization Burden and Outcomes in Congenital Adrenal Hyperplasia Across the Lifespan: Insights from a Swiss Population-Based Cohort Study https://news.medxy.ai/zh/genetics-macronutrient-preferences/Medxy AIzh2026-09-11T08:40:46-07:00遗传因素如何影响宏量营养素偏好及其对儿童饮食与代谢健康的影响 https://news.medxy.ai/ja/genetic-factors-nutrition/Medxy AIja2026-09-11T08:40:26-07:00三大栄養素の嗜好に関わる遺伝要因と、小児の食事摂取・代謝健康への影響 https://news.medxy.ai/vi/genetics-nutrient-preferences/Medxy AIvi2026-09-11T08:39:59-07:00Di truyền chi phối sở thích chất đa lượng và tác động của chúng lên khẩu phần ăn và sức khỏe chuyển hóa ở trẻ em https://news.medxy.ai/genetic-influences-on-macronutrient-preferences-and-their-impact-on-childhood-food-intake-and-metabolic-health/Medxy AIen2026-09-11T08:39:38-07:00Genetic Influences on Macronutrient Preferences and Their Impact on Childhood Food Intake and Metabolic Health https://news.medxy.ai/zh/colorado-child-autoimmune-rate/Medxy AIzh2026-09-11T08:38:54-07:00科罗拉多儿童胰岛自身免疫发生率上升：中等风险HLA基因型队列的纵向研究新发现 https://news.medxy.ai/vi/pancreatic-autoimmunity-colorado/Medxy AIvi2026-09-11T08:38:05-07:00Tỷ lệ tự miễn đảo tụy ở trẻ Colorado tăng rõ rệt, nổi bật ở nhóm HLA nguy cơ trung bình: dữ liệu từ các đoàn hệ theo dõi dọc https://news.medxy.ai/rising-incidence-of-islet-autoimmunity-among-colorado-children-with-moderate-risk-hla-genotypes-insights-from-longitudinal-cohorts/Medxy AIen2026-09-11T08:37:46-07:00Rising Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes: Insights From Longitudinal Cohorts https://news.medxy.ai/zh/aspirin-lipoproteina-calcific-aortic-valve-disease/Medxy AIzh2026-09-11T08:37:00-07:00阿司匹林、脂蛋白(a)与钙化性主动脉瓣疾病：来自多种族动脉粥样硬化研究的启示 https://news.medxy.ai/ja/aspirin-lipoprotein-calcium/Medxy AIja2026-09-11T08:36:36-07:00アスピリン、リポ蛋白(a)、石灰化大動脈弁疾患：Multi-Ethnic Study of Atherosclerosisからの知見 https://news.medxy.ai/vi/aspirin-lipoprotein-a-stenosis/Medxy AIvi2026-09-11T08:36:12-07:00Aspirin, lipoprotein(a) và bệnh van động mạch chủ vôi hóa: Những phát hiện từ Nghiên cứu Đa sắc tộc về Xơ vữa động mạch https://news.medxy.ai/aspirin-use-lipoproteina-and-calcific-aortic-valve-disease-insights-from-the-multi-ethnic-study-of-atherosclerosis/Medxy AIen2026-09-11T08:35:50-07:00Aspirin Use, Lipoprotein(a), and Calcific Aortic Valve Disease: Insights from the Multi-Ethnic Study of Atherosclerosis https://news.medxy.ai/zh/hfpef-risk-model/Medxy AIzh2026-09-11T08:34:53-07:00HFpEF 预后评估再升级：LIFE-Preserved 风险预测模型 https://news.medxy.ai/ja/72557-2/Medxy AIja2026-09-11T08:34:32-07:00HFpEFにおける予後評価の進歩：LIFE-Preservedリスク予測モデル https://news.medxy.ai/vi/hfpref-risk-model/Medxy AIvi2026-09-11T08:34:09-07:00Nâng cao độ chính xác tiên lượng trong HFpEF: mô hình dự báo nguy cơ LIFE-Preserved https://news.medxy.ai/advancing-prognostic-precision-in-hfpef-the-life-preserved-risk-prediction-model/Medxy AIen2026-09-11T08:33:49-07:00Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model https://news.medxy.ai/zh/air-pollution-heart-health/Medxy AIzh2026-09-11T08:32:58-07:00空气污染如何影响心脏健康：慢性PM2.5暴露与冠状动脉内皮功能障碍 https://news.medxy.ai/ja/pm25-heart-damage/Medxy AIja2026-09-11T08:32:34-07:00大気汚染と心臓をつなぐ：PM2.5 慢性曝露と冠動脈内皮機能障害 https://news.medxy.ai/vi/72545-2/Medxy AIvi2026-09-11T08:32:06-07:00Ô nhiễm không khí ảnh hưởng đến sức khỏe tim mạch như thế nào: Tiếp xúc mãn tính với bụi mịn PM2.5 và rối loạn chức năng nội mô mạch vành https://news.medxy.ai/linking-air-pollution-to-heart-health-chronic-pm2-5-exposure-and-coronary-endothelial-dysfunction/Medxy AIen2026-09-11T08:31:41-07:00Linking Air Pollution to Heart Health: Chronic PM2.5 Exposure and Coronary Endothelial Dysfunction https://news.medxy.ai/zh/pci-long-term-benefits-2/Medxy AIzh2026-09-11T08:30:41-07:00QFR指导PCI的长期获益：来自FAVOR III China 5年随访的证据 https://news.medxy.ai/ja/72533-2/Medxy AIja2026-09-11T08:30:23-07:00QFRガイド下PCIの長期的なベネフィット：FAVOR III China試験の5年追跡調査によるエビデンス https://news.medxy.ai/vi/pci-long-term-benefits/Medxy AIvi2026-09-11T08:30:00-07:00Lợi ích dài hạn của PCI được hướng dẫn bởi Quantitative Flow Ratio: Kết quả 5 năm từ thử nghiệm FAVOR III China https://news.medxy.ai/long-term-benefits-of-quantitative-flow-ratio-guided-pci-insights-from-the-5-year-favor-iii-china-trial/Medxy AIen2026-09-11T08:29:42-07:00Long-Term Benefits of Quantitative Flow Ratio-Guided PCI: Insights from the 5-Year FAVOR III China Trial https://news.medxy.ai/zh/lge-genetic-arrhythmia-risk/Medxy AIzh2026-09-11T08:28:53-07:00超越射血分数：LGE通道与遗传标志物助力非缺血性扩张型心肌病心律失常风险分层 https://news.medxy.ai/ja/nonischemic-cardiomyopathy-arrhythmia/Medxy AIja2026-09-11T08:28:37-07:00非虚血性拡張型心筋症の不整脈リスク層別化を前進させる：LGEコリドーと遺伝学的マーカーの役割 https://news.medxy.ai/vi/arrhythmia-risk-stratification/Medxy AIvi2026-09-11T08:28:17-07:00Nâng cao phân tầng nguy cơ loạn nhịp ở bệnh cơ tim giãn không do thiếu máu cục bộ: Vai trò của hành lang LGE và dấu ấn di truyền https://news.medxy.ai/advancing-arrhythmic-risk-stratification-in-nonischemic-dilated-cardiomyopathy-the-role-of-lge-corridors-and-genetic-markers/Medxy AIen2026-09-11T08:27:55-07:00Advancing Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy: The Role of LGE Corridors and Genetic Markers https://news.medxy.ai/zh/macrotroponin-cardiovascular-risk-2/Medxy AIzh2026-09-11T08:27:07-07:00Macrotroponin 复合物与心血管事件风险：心脏肌钙蛋白检测在人群风险分层中的意义 https://news.medxy.ai/ja/macrotroponin-cardiovascular-risk/Medxy AIja2026-09-11T08:26:40-07:00Macrotroponin複合体と心血管イベントリスク：集団リスク層別化における心筋トロポニン検査への示唆 https://news.medxy.ai/vi/macrotroponin-cardiac-risk/Medxy AIvi2026-09-11T08:26:11-07:00Phức hợp macrotroponin và nguy cơ biến cố tim mạch: Hàm ý đối với xét nghiệm troponin tim trong phân tầng nguy cơ quần thể https://news.medxy.ai/macrotroponin-complexes-and-risk-of-cardiovascular-events-implications-for-cardiac-troponin-testing-in-population-risk-stratification/Medxy AIen2026-09-11T08:25:48-07:00Macrotroponin Complexes and Risk of Cardiovascular Events: Implications for Cardiac Troponin Testing in Population Risk Stratification https://news.medxy.ai/zh/internal-medicine-care/Medxy AIzh2026-09-10T08:34:47-07:00强化内科住院医师就诊间照护：结构支持与教育课程的整合实践 https://news.medxy.ai/ja/72156-2/Medxy AIja2026-09-10T08:34:31-07:00内科レジデンシーにおける受診間ケアの強化 https://news.medxy.ai/vi/improving-internal-medicine-care/Medxy AIvi2026-09-10T08:34:13-07:00Nâng cao chăm sóc giữa các lần khám trong đào tạo nội trú Nội khoa: Kết hợp hỗ trợ cơ cấu và chương trình giáo dục https://news.medxy.ai/enhancing-inter-visit-care-in-internal-medicine-residency-integrating-structural-support-and-educational-curriculum/Medxy AIen2026-09-10T08:33:57-07:00Enhancing Inter-Visit Care in Internal Medicine Residency: Integrating Structural Support and Educational Curriculum https://news.medxy.ai/zh/72148-2/Medxy AIzh2026-09-10T08:33:24-07:00居住在疗养院的 Medicare 受益人中呼吸道合胞病毒疫苗的有效性 https://news.medxy.ai/ja/72147-2/Medxy AIja2026-09-10T08:33:07-07:00介護施設に入居するメディケア受給者におけるRSウイルスワクチンの有効性 https://news.medxy.ai/vi/72146-2/Medxy AIvi2026-09-10T08:32:48-07:00Hiệu quả của vắc-xin phòng vi-rút hợp bào hô hấp ở những người thụ hưởng Medicare sống tại các viện dưỡng lão https://news.medxy.ai/respiratory-syncytial-virus-vaccine-effectiveness-in-medicare-beneficiaries-residing-in-nursing-homes-a-comprehensive-review/Medxy AIen2026-09-10T08:32:30-07:00Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes: A Comprehensive Review https://news.medxy.ai/zh/parental-vitamin-b12-folic-acid-birth-defects/Medxy AIzh2026-09-10T08:30:10-07:00父母围受孕期维生素B12与叶酸水平越高，出生缺陷风险越低：大型前瞻性队列研究新发现 https://news.medxy.ai/ja/vitamin-b12-folic-acid-birth-defects/Medxy AIja2026-09-10T08:29:53-07:00受胎前後の親のビタミンB12・葉酸が出生異常リスク低下と関連：大規模前向きコホート研究の知見 https://news.medxy.ai/vi/72141-2/Medxy AIvi2026-09-10T08:29:35-07:00Nồng độ vitamin B12 và axit folic càng cao vào thời điểm thụ thai thì nguy cơ dị tật bẩm sinh càng thấp https://news.medxy.ai/periconceptional-vitamin-b12-and-folate-levels-in-parents-linked-to-birth-defect-risk-reduction-insights-from-a-large-prospective-cohort/Medxy AIen2026-09-10T08:29:17-07:00Periconceptional Vitamin B12 and Folate Levels in Parents Linked to Birth Defect Risk Reduction: Insights from a Large Prospective Cohort https://news.medxy.ai/zh/tp53-mutations-aml/Medxy AIzh2026-09-10T08:28:40-07:00急性髓系白血病中的TP53突变：对同种异基因造血细胞移植后结局的影响 https://news.medxy.ai/ja/tp53-mutation-aml/Medxy AIja2026-09-10T08:28:24-07:00急性骨髄性白血病におけるTP53変異：同種造血細胞移植後転帰への影響 https://news.medxy.ai/vi/tp53-mutations-leukemia/Medxy AIvi2026-09-10T08:28:06-07:00Đột biến TP53 trong bệnh bạch cầu cấp dòng tủy: Tác động lên kết cục sau ghép tế bào tạo máu đồng loài https://news.medxy.ai/tp53-mutations-in-acute-myeloid-leukemia-impact-on-outcomes-post-allogeneic-hematopoietic-cell-transplantation/Medxy AIen2026-09-10T08:27:45-07:00TP53 Mutations in Acute Myeloid Leukemia: Impact on Outcomes Post-Allogeneic Hematopoietic Cell Transplantation https://news.medxy.ai/zh/kmt2a-ptd-mrd/Medxy AIzh2026-09-10T08:27:03-07:00移植前KMT2A-PTD可测量残留病：急性髓系白血病预后分层的新标志物 https://news.medxy.ai/ja/kmt2a-ptd-mrd-marker/Medxy AIja2026-09-10T08:26:47-07:00AMLにおける移植前KMT2A-PTD MRD：予後予測バイオマーカーとしての意義 https://news.medxy.ai/vi/kmt2a-ptd-transplant/Medxy AIvi2026-09-10T08:26:28-07:00KMT2A-PTD trước ghép: dấu ấn tiên lượng đáng chú ý trong ghép tế bào gốc đồng loài ở bệnh bạch cầu tủy cấp https://news.medxy.ai/pre-transplant-kmt2a-ptd-measurable-residual-disease-as-a-prognostic-biomarker-in-acute-myeloid-leukemia-allogeneic-stem-cell-transplantation/Medxy AIen2026-09-10T08:26:11-07:00Pre-Transplant KMT2A-PTD Measurable Residual Disease as a Prognostic Biomarker in Acute Myeloid Leukemia Allogeneic Stem Cell Transplantation https://news.medxy.ai/zh/clonal-hematopoiesis-afa/Medxy AIzh2026-09-10T08:25:36-07:00再生障碍性贫血免疫抑制治疗中的克隆性造血演变：研究发现与临床启示 https://news.medxy.ai/ja/aplastic-anemia-clonality/Medxy AIja2026-09-10T08:25:19-07:00再生不良性貧血におけるクローン性造血の変化：免疫抑制療法下の患者で見えた動態と臨床的意義 https://news.medxy.ai/vi/hematopoiesis-aplasia-treatment/Medxy AIvi2026-09-10T08:24:59-07:00Động học tạo máu dòng vô tính ở bệnh nhân thiếu máu bất sản điều trị ức chế miễn dịch: Những điểm mới và ý nghĩa lâm sàng https://news.medxy.ai/clonal-hematopoiesis-dynamics-in-aplastic-anemia-patients-undergoing-immunosuppressive-therapy-insights-and-clinical-implications/Medxy AIen2026-09-10T08:24:39-07:00Clonal Hematopoiesis Dynamics in Aplastic Anemia Patients Undergoing Immunosuppressive Therapy: Insights and Clinical Implications https://news.medxy.ai/zh/triple-gene-knockout-car-t/Medxy AIzh2026-09-10T08:24:05-07:00CT0590：三重基因敲除异体 BCMA CAR T 疗法推动多发性骨髓瘤与浆细胞白血病治疗进展 https://news.medxy.ai/ja/triple-knockout-car-t/Medxy AIja2026-09-10T08:23:48-07:00CT0590：三重ノックアウト同種異系BCMA CAR T療法が多発性骨髄腫と形質細胞白血病の治療を前進させる https://news.medxy.ai/vi/car-t-therapy-multiple-myeloma/Medxy AIvi2026-09-10T08:23:25-07:00CT0590: Liệu pháp CAR T dị gen BCMA loại bỏ ba gen mở ra hướng điều trị mới cho đa u tủy xương và bạch cầu tương bào https://news.medxy.ai/ct0590-a-triple-knockout-allogeneic-bcma-car-t-therapy-advances-treatment-in-multiple-myeloma-and-plasma-cell-leukemia/Medxy AIen2026-09-10T08:23:04-07:00CT0590: A Triple-Knockout Allogeneic BCMA CAR T Therapy Advances Treatment in Multiple Myeloma and Plasma Cell Leukemia https://news.medxy.ai/zh/copd-lung-cancer-screening/Medxy AIzh2026-09-10T08:22:19-07:00肺癌筛查中的COPD识别新路径：整合定量CT生物标志物提升检出效率 https://news.medxy.ai/ja/copd-detection-lung-cancer/Medxy AIja2026-09-10T08:22:03-07:00肺がん検診におけるCOPD検出を高める：定量的CTバイオマーカー統合の有用性 https://news.medxy.ai/vi/copd-detection-biomarkers/Medxy AIvi2026-09-10T08:21:44-07:00Tăng cường phát hiện COPD nhờ các dấu ấn sinh học CT định lượng tích hợp trong chương trình sàng lọc ung thư phổi https://news.medxy.ai/enhancing-copd-detection-through-integrated-quantitative-ct-biomarkers-in-lung-cancer-screening-programs/Medxy AIen2026-09-10T08:21:24-07:00Enhancing COPD Detection through Integrated Quantitative CT Biomarkers in Lung Cancer Screening Programs https://news.medxy.ai/zh/early-pvod-pch-detection/Medxy AIzh2026-09-10T08:20:41-07:00肺动脉高压中 PVOD/PCH 的早期识别：一种新型临床似然评分的建立 https://news.medxy.ai/ja/pvod-pch-early-detection/Medxy AIja2026-09-10T08:20:26-07:00肺動脈性肺高血圧症における PVOD/PCH の早期同定：新規臨床的発症確率スコアの提案 https://news.medxy.ai/vi/early-pvod-pch-detection-2/Medxy AIvi2026-09-10T08:20:07-07:00Phát hiện sớm PVOD/PCH trong tăng áp động mạch phổi: giới thiệu một thang điểm xác suất lâm sàng mới https://news.medxy.ai/early-identification-of-pvod-pch-in-pulmonary-arterial-hypertension-introducing-a-novel-clinical-likelihood-score/Medxy AIen2026-09-10T08:19:49-07:00Early Identification of PVOD/PCH in Pulmonary Arterial Hypertension: Introducing a Novel Clinical Likelihood Score https://news.medxy.ai/zh/diabetic-macular-edema-trial/Medxy AIzh2026-09-10T08:19:13-07:00突破试验门槛：糖尿病黄斑水肿患者抗VEGF临床试验资格的现实世界评估及其临床与公平性启示 https://news.medxy.ai/ja/diabetic-macular-edema-vegf/Medxy AIja2026-09-10T08:18:56-07:00糖尿病黄斑浮腫における抗VEGF試験の実臨床適格性：臨床実践と健康公平性への示唆 https://news.medxy.ai/vi/diabetic-macular-edema-anti-vegf/Medxy AIvi2026-09-10T08:18:34-07:00Mức độ phù hợp trong thực tế của bệnh nhân phù hoàng điểm do đái tháo đường đối với các thử nghiệm anti-VEGF: Hệ quả đối với thực hành lâm sàng và công bằng y tế https://news.medxy.ai/real-world-eligibility-of-diabetic-macular-edema-patients-for-anti-vegf-trials-implications-for-clinical-practice-and-health-equity/Medxy AIen2026-09-10T08:18:16-07:00Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity https://news.medxy.ai/zh/socioeconomic-deprivation-impact-2/Medxy AIzh2026-09-10T08:17:39-07:00社区社会经济剥夺如何加重声音与反流症状负担：来自三级喉科学门诊的研究 https://news.medxy.ai/ja/socioeconomic-deprivation-impact/Medxy AIja2026-09-10T08:17:21-07:00地域の社会経済的剥奪は声と逆流症状の負担をどう高めるか：三次喉頭科外来からの知見 https://news.medxy.ai/vi/72075-2/Medxy AIvi2026-09-10T08:17:04-07:00Ảnh hưởng của tình trạng thiếu hụt về kinh tế – xã hội tại khu dân cư đến gánh nặng triệu chứng giọng nói và trào ngược: Những hiểu biết từ một phòng khám chuyên khoa thanh quản tuyến cuối https://news.medxy.ai/impact-of-neighborhood-socioeconomic-deprivation-on-voice-and-reflux-symptom-burden-insights-from-a-tertiary-laryngology-clinic/Medxy AIen2026-09-10T08:16:46-07:00Impact of Neighborhood Socioeconomic Deprivation on Voice and Reflux Symptom Burden: Insights from a Tertiary Laryngology Clinic https://news.medxy.ai/zh/minimally-invasive-vs-open-hepatobiliary-surgery/Medxy AIzh2026-09-10T08:16:06-07:00微创与开放肝胆胰外科手术的经济学与患者中心结局：一项为期1年的比较研究 https://news.medxy.ai/ja/72071-2/Medxy AIja2026-09-10T08:15:47-07:00肝胆膵外科における低侵襲手術と開腹手術の経済性および患者中心の転帰：1年間の比較研究 https://news.medxy.ai/vi/minimally-invasive-vs-open-surgery/Medxy AIvi2026-09-10T08:15:28-07:00Phẫu thuật gan-mật-tụy xâm lấn tối thiểu và phẫu thuật mở: So sánh 1 năm về hiệu quả kinh tế và kết cục lấy bệnh nhân làm trung tâm https://news.medxy.ai/economic-and-patient-centered-outcomes-of-minimally-invasive-versus-open-hepatopancreatobiliary-surgery-a-one-year-comparative-study/Medxy AIen2026-09-10T08:15:07-07:00Economic and Patient-centered Outcomes of Minimally Invasive versus Open Hepatopancreatobiliary Surgery: A One-Year Comparative Study https://news.medxy.ai/zh/pennsylvania-rural-health/Medxy AIzh2026-09-09T11:14:32-07:00宾夕法尼亚州农村卫生模式对农村医院癌症手术结局的影响评估 https://news.medxy.ai/ja/pennsylvania-rural-cancer-surgery/Medxy AIja2026-09-09T11:14:18-07:00ペンシルベニア州農村医療モデルは農村病院のがん手術成績にどのような影響を与えたか https://news.medxy.ai/vi/pennsylvania-rural-health-impact/Medxy AIvi2026-09-09T11:14:01-07:00Đánh giá tác động của Mô hình Y tế Nông thôn Pennsylvania đối với kết cục phẫu thuật ung thư tại các bệnh viện nông thôn https://news.medxy.ai/evaluating-the-impact-of-the-pennsylvania-rural-health-model-on-cancer-surgery-outcomes-in-rural-hospitals/Medxy AIen2026-09-09T11:13:43-07:00Evaluating the Impact of the Pennsylvania Rural Health Model on Cancer Surgery Outcomes in Rural Hospitals https://news.medxy.ai/zh/prepregnancy-uterus-surgery-risks/Medxy AIzh2026-09-09T11:13:08-07:00孕前子宫手术或增加早产与死胎风险：大型人群研究揭示重要关联 https://news.medxy.ai/ja/uterine-surgery-preterm-risk/Medxy AIja2026-09-09T11:12:52-07:00初回妊娠前の子宮手術で早産・死産リスク上昇　大規模人口研究が示す実態 https://news.medxy.ai/vi/pre-pregnancy-hysterectomy-risks/Medxy AIvi2026-09-09T11:12:32-07:00Phẫu thuật tử cung trước thai kỳ làm tăng nguy cơ sinh non và thai chết lưu: bằng chứng từ nghiên cứu quần thể lớn https://news.medxy.ai/pre-pregnancy-uterine-surgery-linked-to-increased-risks-of-preterm-birth-and-stillbirth-insights-from-a-large-population-study/Medxy AIen2026-09-09T11:12:13-07:00Pre-pregnancy Uterine Surgery Linked to Increased Risks of Preterm Birth and Stillbirth: Insights from a Large Population Study https://news.medxy.ai/zh/adhd-postpartum-mental-health/Medxy AIzh2026-09-09T11:11:32-07:00妊娠期持续使用精神兴奋剂与ADHD人群产后精神健康：临床证据综述 https://news.medxy.ai/ja/adhd-pregnancy-medication/Medxy AIja2026-09-09T11:11:14-07:00ADHD妊婦における精神刺激薬継続と産後メンタルヘルス：臨床エビデンスレビュー https://news.medxy.ai/vi/adhd-pregnancy/Medxy AIvi2026-09-09T11:10:54-07:00Duy trì psychostimulant trong thai kỳ và sức khỏe tâm thần sau sinh ở người mang thai mắc ADHD: Tổng quan bằng chứng lâm sàng https://news.medxy.ai/psychostimulant-continuation-and-postpartum-mental-health-in-pregnant-people-with-attention-deficit-hyperactivity-disorder-a-clinical-evidence-review/Medxy AIen2026-09-09T11:10:35-07:00Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity Disorder: A Clinical Evidence Review https://news.medxy.ai/zh/72034-2/Medxy AIzh2026-09-09T11:09:36-07:00替奈普酶治疗远端脑动脉闭塞的疗效：基于TASTE随机临床试验的二次分析结果 https://news.medxy.ai/ja/tenecteplase-efficacy/Medxy AIja2026-09-09T11:09:15-07:00遠位脳動脈閉塞におけるテネクテプラーゼの有効性：TASTE無作為化臨床試験の二次解析から得られた知見 https://news.medxy.ai/vi/tenecteplase-effectiveness/Medxy AIvi2026-09-09T11:08:51-07:00Tenecteplase có hiệu quả ra sao trong tắc động mạch não xa? Góc nhìn từ phân tích thứ cấp của thử nghiệm lâm sàng ngẫu nhiên TASTE https://news.medxy.ai/tenecteplase-efficacy-in-distal-cerebral-artery-occlusions-insights-from-the-secondary-analysis-of-the-taste-randomized-clinical-trial/Medxy AIen2026-09-09T11:08:25-07:00Tenecteplase Efficacy in Distal Cerebral Artery Occlusions: Insights From the Secondary Analysis of the TASTE Randomized Clinical Trial https://news.medxy.ai/zh/type-1-diabetes-hypoglycemia-2/Medxy AIzh2026-09-09T11:07:30-07:001型糖尿病中低血糖恐惧与血糖监测指标并非一一对应：一项12个月糖尿病技术研究的启示 https://news.medxy.ai/ja/type-1-diabetes-hypoglycemia/Medxy AIja2026-09-09T11:07:14-07:001型糖尿病における低血糖への恐怖と低血糖指標を切り分ける：12か月間の糖尿病テクノロジー研究から得られた知見 https://news.medxy.ai/vi/fear-hypoglycemia-type-1/Medxy AIvi2026-09-09T11:06:56-07:00Phân tách nỗi sợ và chỉ số hạ đường huyết trong Đái tháo đường typ 1: Kết quả từ nghiên cứu công nghệ đái tháo đường kéo dài 12 tháng https://news.medxy.ai/disentangling-fear-and-hypoglycemia-metrics-in-type-1-diabetes-insights-from-a-12-month-diabetes-technology-study/Medxy AIen2026-09-09T11:06:39-07:00Disentangling Fear and Hypoglycemia Metrics in Type 1 Diabetes: Insights from a 12-Month Diabetes Technology Study https://news.medxy.ai/zh/afib-stroke-risk/Medxy AIzh2026-09-09T11:06:02-07:00心房扑动与心房颤动的缺血性卒中风险差异：来自芬兰全国登记研究的启示 https://news.medxy.ai/ja/stroke-risk-atrial-flutter-fibrillation/Medxy AIja2026-09-09T11:05:44-07:00心房粗動と心房細動で異なる脳卒中リスク：フィンランド全国レジストリ研究からの示唆 https://news.medxy.ai/vi/stroke-risk-atrial-fibrillation/Medxy AIvi2026-09-09T11:05:25-07:00Nguy cơ đột quỵ thiếu máu cục bộ ở cuồng nhĩ so với rung nhĩ: Phát hiện từ nghiên cứu sổ đăng ký toàn quốc tại Phần Lan https://news.medxy.ai/ischaemic-stroke-risk-in-atrial-flutter-versus-atrial-fibrillation-insights-from-a-finnish-nationwide-registry-study/Medxy AIen2026-09-09T11:05:04-07:00Ischaemic Stroke Risk in Atrial Flutter Versus Atrial Fibrillation: Insights from a Finnish Nationwide Registry Study https://news.medxy.ai/zh/heatwave-wildfire-pollution/Medxy AIzh2026-09-09T11:04:27-07:00热浪叠加景观火灾污染：心血管死亡风险进一步升高 https://news.medxy.ai/ja/72010-2/Medxy AIja2026-09-09T11:04:11-07:00猛暑と山火事による汚染が組み合わさると、心血管疾患による死亡のリスクが高まります https://news.medxy.ai/vi/extreme-heat-pollution-heart-risk/Medxy AIvi2026-09-09T11:03:51-07:00Nắng nóng cực đoan kết hợp ô nhiễm do cháy rừng làm gia tăng nguy cơ tử vong tim mạch https://news.medxy.ai/compound-exposure-to-extreme-heat-and-landscape-fire-pollution-amplifies-cardiovascular-mortality-risks/Medxy AIen2026-09-09T11:03:31-07:00Compound Exposure to Extreme Heat and Landscape Fire Pollution Amplifies Cardiovascular Mortality Risks https://news.medxy.ai/zh/aficamten-hcm-2/Medxy AIzh2026-09-09T11:02:56-07:00Aficamten在非梗阻性肥厚型心肌病中的全球疗效：来自ACACIA-HCM及相关研究的启示 https://news.medxy.ai/ja/aficamten-hcm-study/Medxy AIja2026-09-09T11:02:37-07:00非閉塞性肥大型心筋症に対するAficamtenの国際的有効性：ACACIA-HCMと関連試験からみた知見 https://news.medxy.ai/vi/72000-2/Medxy AIvi2026-09-09T11:02:19-07:00Hiệu quả quốc tế của Aficamten đối với bệnh cơ tim phì đại thể không tắc nghẽn: Những hiểu biết từ nghiên cứu ACACIA-HCM và các thử nghiệm liên quan https://news.medxy.ai/global-efficacy-of-aficamten-in-nonobstructive-hypertrophic-cardiomyopathy-insights-from-acacia-hcm-and-complementary-trials/Medxy AIen2026-09-09T11:01:57-07:00Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Insights from ACACIA-HCM and Complementary Trials https://news.medxy.ai/zh/aml-treatment-insights/Medxy AIzh2026-09-09T10:55:34-07:00新诊断不适合强化化疗AML的治疗新思路：Ib期ELEVATE研究解析 https://news.medxy.ai/ja/aml-cusatuzumab-trial/Medxy AIja2026-09-09T10:55:16-07:00強力化学療法非適応の新規AMLにおけるcusatuzumab併用療法を検証：第Ib相ELEVATE試験からの知見 https://news.medxy.ai/vi/elevate-phase-ib-aml/Medxy AIvi2026-09-09T10:54:52-07:00ELEVATE giai đoạn Ib: Đánh giá cusatuzumab phối hợp venetoclax ± azacitidine ở AML mới chẩn đoán nhưng không phù hợp điều trị cường độ cao https://news.medxy.ai/cusatuzumab-venetoclax-aml/Medxy AIen2026-09-09T10:54:31-07:00Evaluating Cusatuzumab Combined with Venetoclax ± Azacitidine in Unfit Newly Diagnosed AML: Insights from the Phase Ib ELEVATE Trial https://news.medxy.ai/zh/metabolism-signal-remodeling/Medxy AIzh2026-09-09T10:53:56-07:00CSNK1A1 E98 突变：del(5q) 骨髓增生异常性肿瘤中的代谢与信号重塑 https://news.medxy.ai/ja/csnk1a1-e98-mutation/Medxy AIja2026-09-09T10:53:37-07:00CSNK1A1 E98変異が示す病態の再構築：del(5q)骨髄異形成性腫瘍における代謝・シグナル変化 https://news.medxy.ai/vi/cskn1a1-mutation-metabolism/Medxy AIvi2026-09-09T10:53:18-07:00Đột biến CSNK1A1 E98: Tái lập trình chuyển hóa và tín hiệu trong tân sinh loạn sản tủy del(5q) https://news.medxy.ai/csnk1a1-e98-mutations-metabolic-and-signaling-rewiring-in-del5q-myelodysplastic-neoplasms/Medxy AIen2026-09-09T10:53:01-07:00Csnk1a1 E98 Mutations: Metabolic and Signaling Rewiring in del(5q) Myelodysplastic Neoplasms https://news.medxy.ai/zh/snorna-hematopoiesis-leukemia-2/Medxy AIzh2026-09-09T10:52:26-07:00揭示 snoRNA 来源 RNA 在造血与急性髓系白血病预后中的作用 https://news.medxy.ai/ja/snorna-hematopoiesis-leukemia/Medxy AIja2026-09-09T10:52:09-07:00snoRNA由来RNAが切り拓く造血と急性骨髄性白血病予後の新たな視点 https://news.medxy.ai/vi/snorna-in-hematopoiesis/Medxy AIvi2026-09-09T10:51:52-07:00Vai trò của các RNA có nguồn gốc từ snoRNA trong quá trình tạo máu và tiên lượng bệnh bạch cầu tủy cấp https://news.medxy.ai/unveiling-the-role-of-snorna-derived-rnas-in-hematopoiesis-and-acute-myeloid-leukemia-prognosis/Medxy AIen2026-09-09T10:51:34-07:00Unveiling the Role of snoRNA-Derived RNAs in Hematopoiesis and Acute Myeloid Leukemia Prognosis https://news.medxy.ai/zh/anti-fibrinolytic-liver-regeneration/Medxy AIzh2026-09-09T10:50:51-07:00抗纤溶治疗促进肝再生并降低肝切除术后肝功能衰竭：从小鼠到人体的转化研究启示 https://news.medxy.ai/ja/liver-regeneration/Medxy AIja2026-09-09T10:50:34-07:00抗線溶薬で肝再生を促進：マウスからヒトへつながる肝切除後肝不全の新知見 https://news.medxy.ai/vi/antifibrinolytic-liver-regeneration/Medxy AIvi2026-09-09T10:50:17-07:00Tác nhân chống tiêu sợi huyết thúc đẩy tái tạo gan và giảm suy gan sau cắt gan: Góc nhìn chuyển dịch từ chuột sang người https://news.medxy.ai/antifibrinolytic-agents-enhance-liver-regeneration-and-reduce-posthepatectomy-liver-failure-translational-insights-from-mice-to-humans/Medxy AIen2026-09-09T10:49:59-07:00Antifibrinolytic Agents Enhance Liver Regeneration and Reduce Posthepatectomy Liver Failure: Translational Insights from Mice to Humans https://news.medxy.ai/zh/retinoic-acid-gvhd/Medxy AIzh2026-09-09T10:49:26-07:00视黄酸驱动的CD16^hi^CD177+中性粒细胞：激素抵抗性GI-GVHD的新治疗靶点 https://news.medxy.ai/ja/71956-2/Medxy AIja2026-09-09T10:49:09-07:00レチノイン酸により誘導されるCD16^hi^CD177+好中球：ステロイド抵抗性消化管GVHDに対する新規治療標的 https://news.medxy.ai/vi/cd16hi-cd177-neutrophils-gvhd/Medxy AIvi2026-09-09T10:48:52-07:00Nhắm trúng đích bạch cầu trung tính CD16hiCD177+ do acid retinoic thúc đẩy trong GI-GVHD kháng steroid: một hướng điều trị mới https://news.medxy.ai/targeting-retinoic-acid-driven-cd16hicd177-neutrophils-in-steroid-resistant-gi-gvhd-a-novel-therapeutic-avenue/Medxy AIen2026-09-09T10:48:36-07:00Targeting Retinoic Acid-Driven CD16hiCD177+ Neutrophils in Steroid-Resistant GI-GVHD: A Novel Therapeutic Avenue https://news.medxy.ai/zh/cpap-expiratory-relief/Medxy AIzh2026-09-09T10:47:59-07:00CPAP治疗中的呼气压力缓解：对上气道通畅性与阻塞性睡眠呼吸暂停控制的影响 https://news.medxy.ai/ja/71948-2/Medxy AIja2026-09-09T10:47:43-07:00CPAP療法における呼気圧緩和：上気道の開存性および閉塞性睡眠時無呼吸の制御への影響 https://news.medxy.ai/vi/71946-2/Medxy AIvi2026-09-09T10:47:24-07:00Tối ưu hóa kỳ vọng và kết quả điều trị của bệnh nhân: Diễn giải chỉ số “Số ngày sống và không nằm viện” sau ghép phổi https://news.medxy.ai/expiratory-pressure-alleviation-in-cpap-therapy-impact-on-upper-airway-patency-and-obstructive-sleep-apnea-control/Medxy AIen2026-09-09T10:47:06-07:00Expiratory Pressure Alleviation in CPAP Therapy: Impact on Upper Airway Patency and Obstructive Sleep Apnea Control https://news.medxy.ai/zh/patient-outcomes-lung-transplant/Medxy AIzh2026-09-09T10:46:28-07:00优化患者预期与结局：解读肺移植后的存活且院外天数 https://news.medxy.ai/ja/post-lung-transplant-survival/Medxy AIja2026-09-09T10:46:13-07:00肺移植後の入院外生存日数を読み解く：患者期待と転帰を最適化するために https://news.medxy.ai/vi/lung-transplant-outcomes/Medxy AIvi2026-09-09T10:45:54-07:00Tối ưu hóa kỳ vọng và kết cục của người bệnh: Hiểu về số ngày còn sống và ở ngoài bệnh viện sau ghép phổi https://news.medxy.ai/optimizing-patient-expectations-and-outcomes-understanding-days-alive-and-out-of-hospital-after-lung-transplantation/Medxy AIen2026-09-09T10:45:34-07:00Optimizing Patient Expectations and Outcomes: Understanding Days Alive and Out of Hospital After Lung Transplantation https://news.medxy.ai/zh/copd-stability/Medxy AIzh2026-09-09T10:45:01-07:00COPD疾病稳定性如何定义与实现：来自Ⅲ期试验的启示 https://news.medxy.ai/ja/copd-stability-2/Medxy AIja2026-09-09T10:44:45-07:00COPDの疾患安定性をどう定義し、どう達成するか：第3相試験からの示唆 https://news.medxy.ai/vi/copd-stability-goals/Medxy AIvi2026-09-09T10:44:24-07:00Xác định và đạt mục tiêu ổn định bệnh trong COPD: Những phân tích từ các thử nghiệm pha 3 https://news.medxy.ai/defining-and-achieving-disease-stability-in-copd-insights-from-phase-3-trials/Medxy AIen2026-09-09T10:44:06-07:00Defining and Achieving Disease Stability in COPD: Insights from Phase 3 Trials https://news.medxy.ai/zh/bronchiectasis-exacerbation-phenotype/Medxy AIzh2026-09-09T10:43:31-07:00支气管扩张症中“频繁急性加重者”表型需重新审视：来自 EMBARC 登记研究的启示 https://news.medxy.ai/ja/71917-2/Medxy AIja2026-09-09T10:43:14-07:00気管支拡張症における頻回増悪型（Frequent Exacerbator Phenotype）の再評価：EMBARCレジストリからの知見 https://news.medxy.ai/vi/frequent-exacerbation-bronchiectasis/Medxy AIvi2026-09-09T10:42:55-07:00Xem xét lại kiểu hình người kịch phát thường xuyên trong giãn phế quản: Góc nhìn từ cơ sở dữ liệu EMBARC https://news.medxy.ai/reevaluating-the-frequent-exacerbator-phenotype-in-bronchiectasis-insights-from-the-embarc-registry/Medxy AIen2026-09-09T10:42:37-07:00Reevaluating the Frequent Exacerbator Phenotype in Bronchiectasis: Insights from the EMBARC Registry https://news.medxy.ai/zh/atopic-disease-keratoconus/Medxy AIzh2026-09-09T10:42:01-07:00累积性特应性疾病负担与圆锥角膜：来自大规模横断面与纵向分析的启示 https://news.medxy.ai/ja/atopic-keratoconus/Medxy AIja2026-09-09T10:41:43-07:00累積アトピー性疾患負荷と角膜円錐症：大規模横断・縦断解析から見えてきた知見 https://news.medxy.ai/vi/atopy-keratoconus-burden/Medxy AIvi2026-09-09T10:41:22-07:00Gánh nặng bệnh atopy tích lũy và keratoconus: Góc nhìn từ các phân tích cắt ngang và dọc quy mô lớn https://news.medxy.ai/cumulative-atopic-disease-burden-and-keratoconus-insights-from-large-scale-cross-sectional-and-longitudinal-analyses/Medxy AIen2026-09-09T10:41:03-07:00Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses https://news.medxy.ai/zh/obesity-dry-eye-gender/Medxy AIzh2026-09-09T10:40:15-07:00肥胖与干眼病的性别差异关联：来自大规模 UK Biobank 研究的启示 https://news.medxy.ai/ja/71902-2/Medxy AIja2026-09-09T10:39:58-07:00肥満とドライアイ疾患との性差のある関連：大規模UKバイオバンク研究からの知見 https://news.medxy.ai/vi/obesity-dry-eye/Medxy AIvi2026-09-09T10:39:38-07:00Béo phì và bệnh khô mắt: mối liên hệ khác nhau theo giới từ một nghiên cứu quy mô lớn của UK Biobank https://news.medxy.ai/sex-specific-associations-between-adiposity-and-dry-eye-disease-insights-from-a-large-uk-biobank-study/Medxy AIen2026-09-09T10:39:19-07:00Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study https://news.medxy.ai/zh/glaucoma-progression-detection/Medxy AIzh2026-09-09T10:38:36-07:00青光眼进展的事件驱动检测：整合 OCT、OCTA 与视野指标 https://news.medxy.ai/ja/glaucoma-progression/Medxy AIja2026-09-09T10:38:17-07:00緑内障の進行をイベントベースで捉える：OCT・OCT血管撮影・視野指標の統合 https://news.medxy.ai/vi/glaucoma-progression-events/Medxy AIvi2026-09-09T10:37:55-07:00Phát hiện tiến triển glôcôm theo sự kiện: tích hợp OCT, OCTA và các chỉ số thị trường https://news.medxy.ai/event-based-progression-detection-in-glaucoma-integrating-oct-oct-angiography-and-visual-field-metrics/Medxy AIen2026-09-09T10:37:33-07:00Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics https://news.medxy.ai/zh/71886-2/Medxy AIzh2026-09-09T10:36:38-07:00高度近视患者眼球三维形态的纵向变化及病理性后遗症：对个性化监测的启示 https://news.medxy.ai/ja/high-myopia-eye-shape/Medxy AIja2026-09-09T10:36:14-07:00高度近視における3次元眼球形状の縦断的変化と病的後遺症：個別化サーベイランスへの示唆 https://news.medxy.ai/vi/3d-eye-shape-myriasis/Medxy AIvi2026-09-09T10:35:54-07:00Quỹ đạo theo thời gian của hình dạng mắt 3 chiều và các di chứng bệnh lý trong cận thị nặng: hàm ý cho theo dõi cá thể hóa https://news.medxy.ai/longitudinal-trajectories-of-3-dimensional-eye-shape-and-pathological-sequelae-in-high-myopia-implications-for-personalized-surveillance/Medxy AIen2026-09-09T10:35:33-07:00Longitudinal Trajectories of 3-Dimensional Eye Shape and Pathological Sequelae in High Myopia: Implications for Personalized Surveillance https://news.medxy.ai/zh/impact-of-research-output/Medxy AIzh2026-09-09T10:34:44-07:00专门研究年对耳鼻咽喉科住院医师申请者学术产出的真实影响有多大？ https://news.medxy.ai/ja/otolaryngology-research-impact/Medxy AIja2026-09-09T10:34:29-07:00耳鼻咽喉科レジデンシー志望者における専従研究年の真の効果を検証する https://news.medxy.ai/vi/impact-specialized-research/Medxy AIvi2026-09-09T10:34:12-07:00Đánh giá tác động thực sự của một năm nghiên cứu chuyên biệt đối với đầu ra học thuật của ứng viên nội trú Tai Mũi Họng https://news.medxy.ai/evaluating-the-true-impact-of-a-dedicated-research-year-on-otolaryngology-residency-applicants-scholarly-output/Medxy AIen2026-09-09T10:33:56-07:00Evaluating the True Impact of a Dedicated Research Year on Otolaryngology Residency Applicants’ Scholarly Output https://news.medxy.ai/zh/zenker-dysphagia/Medxy AIzh2026-09-09T10:33:17-07:00Zenker 憩室相关环咽肌功能障碍术后吞咽困难：持续性与复发性的区分——来自 POuCH 研究的启示 https://news.medxy.ai/ja/zenker-diverticulum-swallowing/Medxy AIja2026-09-09T10:32:57-07:00Zenker憩室合併輪状咽頭筋機能障害手術後の持続性・再発性嚥下障害をどう見分けるか：POuCH研究からの知見 https://news.medxy.ai/vi/dysphagia-differentiation/Medxy AIvi2026-09-09T10:32:35-07:00Phân biệt nuốt khó dai dẳng và nuốt khó tái phát sau phẫu thuật rối loạn chức năng cơ nhẫn hầu kèm túi thừa Zenker: Góc nhìn từ nghiên cứu POuCH https://news.medxy.ai/differentiating-persistent-and-recurrent-dysphagia-after-surgery-for-cricopharyngeal-muscle-dysfunction-with-zenker-diverticulum-insights-from-the-pouch-study/Medxy AIen2026-09-09T10:32:17-07:00Differentiating Persistent and Recurrent Dysphagia After Surgery for Cricopharyngeal Muscle Dysfunction with Zenker Diverticulum: Insights from the POuCH Study https://news.medxy.ai/zh/decompensated-cirrhosis-impact-2/Medxy AIzh2026-09-09T10:31:33-07:00失代偿性肝硬化对心脏外科手术结局的影响：临床与经济学意义 https://news.medxy.ai/ja/incomplete-liver-cirrhosis-impact/Medxy AIja2026-09-09T10:31:17-07:00代償不全肝硬変が心臓手術成績に及ぼす影響：臨床的・経済的意義 https://news.medxy.ai/vi/decompensated-cirrhosis-impact/Medxy AIvi2026-09-09T10:30:58-07:00Xơ gan mất bù ảnh hưởng thế nào đến kết quả phẫu thuật tim? Hệ lụy lâm sàng và kinh tế https://news.medxy.ai/impact-of-decompensated-cirrhosis-on-cardiac-surgery-outcomes-clinical-and-economic-implications/Medxy AIen2026-09-09T10:30:42-07:00Impact of Decompensated Cirrhosis on Cardiac Surgery Outcomes: Clinical and Economic Implications https://news.medxy.ai/zh/71849-2/Medxy AIzh2026-09-09T10:30:07-07:00成人活体肝移植血管重建的新进展：深部左肝门蒂解剖联合脐部原位解剖 https://news.medxy.ai/ja/adult-liver-transplantation-vascular-reconstruction/Medxy AIja2026-09-09T10:29:48-07:00成人生体肝移植における血管再建の新展開：in situ 臍部剥離を伴う深部左肝門ペディクル分離 https://news.medxy.ai/vi/liver-transplant-vascular-regeneration/Medxy AIvi2026-09-09T10:29:30-07:00Nâng cao tái tạo mạch máu trong ghép gan từ người hiến sống ở người lớn: Cô lập cuống rốn gan trái sâu kết hợp bóc tách tại chỗ phần rốn của tĩnh mạch cửa https://news.medxy.ai/advancing-vascular-reconstruction-in-adult-living-donor-liver-transplantation-deep-left-hilar-pedicle-isolation-with-in-situ-umbilical-portion-dissection/Medxy AIen2026-09-09T10:29:13-07:00Advancing Vascular Reconstruction in Adult Living Donor Liver Transplantation: Deep Left Hilar Pedicle Isolation with In Situ Umbilical Portion Dissection